| | Class 1 Device Recall Arrow Kits and Sets that contain Lidocaine and Bupivacaine |  |
| Date Initiated by Firm | April 21, 2026 |
| Date Posted | June 13, 2026 |
| Recall Status1 |
Open3, Classified |
| Recall Number | Z-2373-2026 |
| Recall Event ID |
98793 |
| 510(K)Number | K984022 K993933 |
| Product Classification |
Catheter, hemodialysis, non-implanted - Product Code MPB
|
| Product | Description/REF:
HEMODIALYSIS KIT: 2-LUMEN 8 FR X 11 CM/AK-11802-F;
HEMODIALYSIS KIT: 2-LUMEN 12 FR X 16 CM/AK-22122;
HEMODIALYSIS KIT 2L: 14 FR X 15CM AGB/AK-22142-CDC;
HEMODIALYSIS KIT 2L: 14 FR X 20CM AGB/AK-25142-CDC;
HEMODIALYSIS KIT: 2L 14 FR X 15 CM/ASK-22142-UMD;
HEMODIALYSIS KIT: 2L 14 FR X 15 CM/ASK-22142-UNC;
HEMODIALYSIS KIT: 2L 14 FR X 20 CM/ASK-25142-UMD;
HEMODIALYSIS KIT 2L: 14 FR X 20 CM AGB/ASK-25142-UN1;
HEMODIALYSIS KIT: 2L 14 FR X 25 CM/ASK-26142-UMD;
HEMODIALYSIS KIT: 2LUMEN 12 FR X 13 CM/AU-23122-F;
HEMODIALYSIS KIT: 2LUMEN 12 FR X 20 CM/AU-25122-F;
HEMODIALYSIS KIT: 2L 12 FR X 16 CM AGB/CDC-22122-X1A;
HEMODIALYSIS KIT: 2L 12 FR X 16 CM AGB/CDC-22122-XU1A;
HEMODIALYSIS KIT: 2L 14 FR X 15 CM AGB/CDC-22142-X1A;
HEMODIALYSIS KIT: 2L 12 FR X 25 CM AGB/CDC-26122-X1A;
HEMODIALYSIS KIT 2L: 12 FR X 16CM AGB/AK-22122-CDC;
HEMODIALYSIS KIT: 2-LUMEN 12 FR X 16 CM/AK-22122-F;
HEMODIALYSIS KIT: 2-LUMEN 14 FR X 15 CM/AK-22142-F;
AHDC AGB U-BEND KIT: 2-L 12 FR X 16 CM/CDC-22122-CN1AU;
AHDC AGB CURVED KIT: 2-L 14 FR X 15 CM/CDC-22142-CN1AC;
AHDC AGB U-BEND KIT: 2-L 12 FR X 13 CM/CDC-23122-CN1AU;
AHDC AGB U-BEND KIT: 2-L 12 FR X 20 CM/CDC-25122-CN1AU;
AHDC AGB CURVED KIT: 2-L 14 FR X 20 CM/CDC-25142-CN1AC; |
| Code Information |
REF(Material)/UDI-DI/Lot(Batch):
AK-11802-F/10801902193275, 10801902197129/33F24G0344, 33F24J0511, 33F24L0637, 33F25A0473, 33F25E0060, 33F25J0473, 33F24A0848;
AK-22122/10801902193275/33F24H0232, 33F24J0523;
AK-22142-CDC/10801902193275/33F24J0527, 33F24K0129, 33F24L0649, 33F25C0115, 33F25C0959, 33F25E0940, 33F25J0481, 33F25L0428, 33F24G0364;
AK-25142-CDC/10801902193275, 50801902123195/33F25A0486, 33F25C0892, 33F25E0086, 33F25E0944, 33F25J0485, 33F25J0845, 33F25L0374, 33F26B0521, 33F25A0487;
ASK-22142-UMD/10801902193275, 10801902136470, 10801902143690/33F25F0362, 33F25J0094, 33F26A0244, 33F26B0137, 33F24F0041;
ASK-22142-UNC/10801902193275/33F25G0269, 33F24K0560;
ASK-25142-UMD/10801902193275, 10801902136500/33F25B0239, 33F25E0308, 33F25G0686, 33F25K0425, 33F26A0246, 33F26C0047, 33F24K0696;
ASK-25142-UN1/10801902193275, 10801902156379/33F24L1157, 33F26B0908, 33F25B0420;
ASK-26142-UMD/10801902193275, 33F26A0408, 33F25B0427;
AU-23122-F/10801902193275/33F25C0877, 33F25H0157, 33F24L0038;
AU-25122-F/10801902193275, 70801902123328, 10801902210071/33F25G0562, 33R24L0038, 33F24D0400;
CDC-22122-X1A/10801902193275, 10801902213478/33F25E0694, 33F25G0268, 33F24D0693;
CDC-22122-XU1A/10801902193275, 10801902168044/33F25E0652, 33F25H0643, 33F24D0830;
CDC-22142-X1A/10801902193275/33F25A0284;
CDC-26122-X1A/10801902213515/33F24F1028;
AK-22122-CDC/10801902193275, 10801902198492/33F24K0125, 33F24L0647, 33F25C0114, 33F25E0936, 33F25G0091, 33F24E0355;
AK-22122-F/10801902193275/33F24G0360, 33F24J0524, 33F24K0126, 33F25A0482, 33F25E0075, 33F25E0937, 33F25J0839, 33F25L0413, 33F24G0361;
AK-22142-F/10801902193275/33F24L0662, 33F25C0117, 33F25C0865, 33F25H0034, 33F25J0841, 33F24K0130;
CDC-22122-CN1AU/10801902193275, 10801902222265/33F26A1388, 33F26B0398, 33F24L0966;
CDC-22142-CN1AC/10801902193275/33F26A1550, 33F25J0455;
CDC-23122-CN1AU/10801902193275, 10801902222319/33F26A0008, 33F26A1478, 33F26B0397, 33F24L0279;
CDC-25122-CN1AU/10801902193275/33F25M0346, 33F25E0882;
CDC-25142-CN1AC/30801902123597/36F25B0018
|
| FEI Number |
3013162291
|
Recalling Firm/ Manufacturer |
ARROW INTERNATIONAL, LLC 3015 Carrington Mill Blvd Morrisville NC 27560-5437
|
| For Additional Information Contact | Customer Service 866-396-2111 |
Manufacturer Reason for Recall | Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries. |
FDA Determined Cause 2 | Nonconforming Material/Component |
| Action | On 4/21/2026, correction notices (Firm Event Number: EIF-000608, lidocaine and bupivacaine) were mailed to customers who were asked to do the following:
Arrow International LLC is voluntarily recalling product due to the Huons Co. Ltd. recall of Lidocaine and Bupivacaine, which is included in impacted Arrow Kits & Sets.
Medical facilities
1. Provide this correction notice to all persons who need to be aware within your organization or to any organization where the potentially affected product has been transferred.
2. Check your inventory for product within the scope of this Medical Device Notification and place a copy of this notice with all affected product.
3. Complete and return the response form virtually via:
https://fca.myteleflex.com/en/recall/000608
Distributors:
1. Provide Medical Device Notification to all customers who have received impacted product. Each of your customers is then required to complete the Acknowledgement Form and return it to you as their distributor.
2. Check your inventory for affected product. Place a copy of this notification with all affected product and ensure that the notification is included with future distributions of affected product.
3. Complete and return the response form via link: https://fca.myteleflex.com/en/recall/000608
4. If you have further distributed product outside of your country, please notify Teleflex Customer Service by return email.
If you have questions contact firm's Customer Service:
Link: https://fca.myteleflex.com/en/recall/000608,
Customer Service: Telephone: 1-866-396-2111,
FAX: 1-855-419-8507 Email: Recalls@teleflex.com
On 5/29/2026, additional amended notices (Firm Event Number: EIF-000608-01) were mailed to include additional affected devices.
On 5/1/2026, additional notices (Firm Event Number: EIF-000609, sodium chloride) were mailed and emailed to customers who have 0.9% sodium chloride (10mL saline solution ampule) in kits and sets. |
| Quantity in Commerce | 15,425 |
| Distribution | US Nationwide distribution including in the states of VA, NY, UT, SC, LA, MN, PA, AZ, CA, MI, OH, FL, CT, KS, IL, TX, WI, GA, NC, MD, OR, AK, NH, IA, ND, OK, NM, AL, MA, KY, WA, AR, CO, IN, ME, TN, WY, NJ, SD, MS, MO, MT, DE, ID, NE, WV, RI, VT, NV, HI, DC, PR.
|
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
| 510(K) Database | 510(K)s with Product Code = MPB
|
|
|
|